Revenue

Agilent's new S540MD scanner aims to tackle lab backlogs and boost diagnostic speed with high-throughput capacity and AI-powered automation.

Acrivon Therapeutics to unveil pivotal data showing high response rates for its targeted drug ACR-368 in an aggressive endometrial cancer subtype.

Chris Antonopoulos, who led Lekela Power to a billion-dollar exit, invests and joins the board of fuel cell innovator Advent Technologies.

Exclusive: Lidar pioneer David Hall returns to CES. We discuss the engineering physics of his new ventures and the secret to solving "impossible" problems.

Ontario's new FAST program provides accelerated funding for two key cancer drugs, cutting patient wait times and setting a new standard for access in Canada.

An Israeli firm unveils MORPHIT, a patented technology that transforms unsorted construction waste into load-bearing blocks, promising a circular economy.

Fermi.ai, a new edtech platform from tech titans, rejects instant AI answers to restore 'productive struggle' and transform high school STEM education.

The Canadian miner sheds over $800M in debt, streamlining its portfolio to focus on high-return growth projects in Canada and the United States.

As Shoals preps its 2025 results, investors watch for signs of health in the renewable sector and progress in its strategic pivot to battery storage.

Dealers battle slow sites and clunky tools. Team Velocity’s Apollo platform uses native integrations to boost speed, cut costs, and fix the CX.

A massive B.C. nickel project, vital for the EV revolution, enters environmental review, testing a new model for resource and First Nations partnership.

SilverBox Corp V's shares and warrants now trade separately. Here's what it means for investors and the SPAC's hunt for its next big acquisition.

New 24-month data suggests a novel drug could improve kidney function and reduce side effects for transplant patients, challenging a decades-old standard.

Navia Markets launches an independent emergency tool for traders, raising the bar for investor protection in an era of platform instability.

A surprise A-list cast led by Benedict Cumberbatch read for charity in a sold-out show blending luxury travel with the timeless power of the written word.

A new logistics tech giant, SKG, emerges from a three-way merger, eyeing a Nasdaq IPO and leveraging AI to disrupt global supply chains from Asia to the U.S.

Ossium Health's groundbreaking study using banked bone marrow from deceased donors could solve the critical shortage of transplant matches for patients.

Dechert launches a Houston office led by trial star Jim Wetwiska, a strategic move in the Big Law talent wars to dominate the energy and tech sectors.

Robo.ai partners with The Ghazi Group in a landmark deal, transforming into a key compute provider for the booming AI markets in MENA and Southeast Asia.

Mark43's new Manchester HQ brings high-tech jobs and a new police records system, aiming to end years of IT failures at Greater Manchester Police.